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on the transcriptional level via a high-throughput RT-qPCR 
technique by quantifying the impact of BPDE on the tran-
scription of 95 genes comprising DNA damage response, 
DNA repair factors, oxidative stress response, cell cycle 
arrest, cell proliferation, and apoptosis. As expected, BPDE 
activated DNA damage signaling, p53 and AP-1 dependent 
signaling, oxidative stress response, and apoptosis. How-
ever, in contrast to DNA adducts and mutations, the onset 
of the transcriptional DNA damage response was restricted 
to higher concentrations, indicating that its respective acti-
vations require a certain level of DNA lesions. Altogether, 
the results indicate that in case of BPDE, DNA lesions and 
mutations were correlated at all concentrations, suggesting 
that repair is not complete even at low levels of DNA dam-
age. Considering the ongoing discussion on potential thresh-
olds also for genotoxic carcinogens, the results are of major 
relevance, both with respect to basic research as well as to 
risk assessment of chemical carcinogens.
Keywords BPDE · DNA adducts · DNA repair · 
Mutations · Gene expression profiling · High throughput 
RT-qPCR
Introduction
In spite of manifold precautions to reduce exposure towards 
hazardous chemicals, there are still many carcinogens pre-
sent in the environment, at workplaces, and in food. They 
comprise combustion products, carcinogenic metal com-
pounds, carcinogenic organic chemicals, natural bioactive 
food ingredients as well as carcinogens generated during 
storage, production, and preparation of food, such as myco-
toxins, acrylamide, nitrosamines, and polycyclic aromatic 
hydrocarbons. Even though exposure levels have dropped 
Abstract Benzo[a]pyrene is a known human carcinogen. As 
underlying mechanism, the induction of stable DNA adducts 
and mutations have been repeatedly demonstrated. Also, the 
activation of cellular stress response on the transcriptional 
level has been described. Nevertheless, the interrelationship 
between these different events is less well understood, espe-
cially at low, for human exposure relevant concentrations. 
Within the present study, we applied the reactive metabo-
lite benzo[a]pyrene diolepoxide (BPDE) in the nanomolar, 
non-cytotoxic concentration range in human TK6 cells and 
quantified the induction and repair of stable DNA adducts 
at the N2-position of guanine by HPLC with fluorescence 
detection. Significant levels of DNA lesions were detected 
even at the lowest concentration of 10 nM BPDE, with a lin-
ear increase up to 50 nM. Relative repair was similar at all 
damage levels, reaching about 30% after 8 h and 60% after 
24 h. Mutation frequencies were quantified as GPI-deficient 
cells by the recently established in vitro PIG-A mutagenic-
ity assay. Again, a linear dose–response-relationship in the 
before-mentioned concentration range was observed, also 
when plotting the number of GPI-deficient cells against the 
number of DNA adducts. Furthermore, we explored the 
time- and concentration-dependent DNA damage response 
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considerably during the last decades, this raises the ques-
tion whether or not there is a carcinogenic risk under real-
istic exposure conditions. Especially directly genotoxic, 
i.e., DNA-reactive agents or their DNA-reactive metabo-
lites, are generally assumed to represent risk factors at any 
concentration, following a linear dose–response also in 
the low concentration range, implying that even one or a 
few DNA lesions may result in mutations, and thus, may 
increase tumor risk. This assumption has repeatedly been 
challenged during the last years, due to observations that, 
for example, in case of alkylating compounds such as EMS 
DNA lesions are linear also in the low dose range, while 
increases in mutation frequencies follow a non-linear dose–
response relationship (Doak et al. 2007; Gocke and Müller 
2009; Jenkins et al. 2010; Pottenger et al. 2009; for recent 
review see Klapacz et al. 2016). This raised the question 
whether this may apply for all genotoxic substances, due 
to, for example, complete repair, as well as other DNA 
damage response systems in cases of low levels of DNA 
damage, which are overwhelmed in case of higher levels 
of DNA adducts (Greim and Albertini 2014; Klapacz et al. 
2016). Clearly, with respect to a potential impairment of 
genomic stability, a distinction has to be made between the 
occurrence of DNA adducts, which may be repaired, and 
there conversion into mutations, i.e., irreversible alteration 
of the genetic information. Nevertheless, repair efficien-
cies in the low dose range may be different in case of DNA 
lesions generated also endogenously, such as DNA alkyla-
tion damage to DNA bases, and lesions induced exclusively 
or predominantly by environmental mutagens. While cells 
may be very well adapted to remove oxidatively induced 
DNA lesions and most types of DNA base damage induced 
by alkylating agents via base excision repair (BER), many 
classes of environmental mutagens such as polycyclic aro-
matic hydrocarbons (PAHs) induce DNA lesions which 
provoke DNA helix distortions repaired by nucleotide exci-
sion repair (NER). As compared to BER, the latter repair 
pathway is usually slower and not evenly efficient through-
out the genome (Fousteri and Mullenders 2008).
Within the present study we addressed the question 
on dose–response relationships in the low dose range for 
benzo[a]pyrene (BaP)-induced DNA adducts, their repair, 
the transcriptional DNA damage response, and the induc-
tion of mutations in the same cell line, namely TK6 cells. 
BaP belongs to the group of PAHs formed during incom-
plete combustion or pyrolysis of organic material. Expo-
sure to BaP provokes manifold adverse effects, including 
carcinogenicity, immunosuppression, teratogenicity, as 
well as hormonal effects (Verma et al. 2012). The car-
cinogenic activity of BaP is attributed to the formation 
of DNA adducts, resulting from electrophilic attack pre-
dominantly at guanine residues by metabolically activated 
intermediates formed from the parent hydrocarbon. Routes 
of metabolic activation include the formation of radical 
cations via P450 and/or peroxidases and the formation of 
o-quinones via dihydrodiol dehydrogenases. For carcino-
genicity, the probably most relevant metabolic pathway is 
connected to the action of cytochromes P450 1A1 and 1B1 
and epoxide hydrolase, yielding syn- and anti-BaP-7,8-
diol 9,10-epoxides (BPDE), which mainly form adducts 
at the N2 position of guanine. These lesions are substrates 
of nucleotide excision repair (NER) (Camenisch and Nae-
geli 2009; Hess et al. 1997). When DNA is replicated prior 
to their removal, these adducts can lead to mutations and 
cancer (Melendez-Colon et al. 1999). To exclude cellu-
lar detoxification of BaP preceding the induction of DNA 
lesions, within the present study cells were treated with 
its DNA reactive metabolite, (+)-anti-benzo[a]pyrene 
7,8-diol-9,10-epoxide [(+)-anti-BPDE]. Mutations were 
quantified via the in vitro PIG-A mutagenicity test, which 
has been recently established for TK6 cells (Krüger et al. 
2015). Therefore, to ensure comparable conditions, this cell 
line was applied for all other endpoints as well. For quan-
tification of (+)-anti-BPDE-induced DNA adducts a highly 
sensitive HPLC-based assay coupled with fluorescence 
detection was used, enabling the detection of the respec-
tive tetrol I-1 in the very low dose range (Schwerdtle et al. 
2002). Finally, we applied a high-throughput RT-qPCR 
approach to quantitatively elucidate the onset of the tran-
scriptional DNA damage response at the same conditions 
(Fischer et al. 2016). Our results demonstrate a linear cor-
relation between the amount of DNA adducts and muta-
tions even in the very low concentration range, indicating 
no threshold-like effect for the conversion of DNA adducts 
into mutations. Furthermore, the transcriptional DNA dam-
age response was restricted to higher concentrations, at 
which mutations were already evident.
Materials and methods
Materials
RPMI-1640 medium, trypsin, dimethyl sulfoxide (DMSO), 
and penicillin–streptomycin solutions were purchased 
from Sigma-Aldrich (Steinheim, Germany) and fetal 
bovine serum (FBS) from Invitrogen GmbH (Darmstadt, 
Germany). Cell culture dishes were from Sarstedt (Nuem-
brecht, Germany). (+)-anti-benzo[a]pyrene-7,8-diol 
9,10-epoxide ((+)-anti-BPDE) was synthesized by Dr. 
A. Seidel, Biochemisches Institut für Umweltcarcinogene 
Grimmer (Grosshansdorf, Germany). Mouse anti-human 
CD55-PE (clone JS11), mouse anti-human CD59-PE (clone 
p282), mouse anti-human CD19-APC (clone HIB 19), 
mouse anti-human CD59 (clone p282), goat anti-mouse 
IgG (polyclonal), and 7-aminoactinomycin D solution 
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(7-AAD, CAS Nr. 7240-37-1) were purchased from Bio-
legend (London, United Kingdom). Actinomycin D (AD, 
CAS Nr. 50-76-0) and cycloheximide (CAS Nr. 66-81-9, 
purity ≥96%) were obtained from Carl Roth (Karlsruhe, 
Germany). Proaerolysin (CAS Nr. 110616-75-6) was pro-
vided by Dr. Peter Howard (University of Saskatchewan, 
Canada). Cellstar cell culture dishes (for mutant cleansing), 
35 × 10 mm, were purchased from Greiner bio-one (Frick-
enhausen, Germany). All PCR consumables including PCR 
tubes and strips were obtained from Sarstedt (Nuembrecht, 
Germany). The primer pairs were synthesized by Eurofins 
(Ebersberg, Germany) or Fluidigm (San Francisco, USA). 
DNA suspension buffer, PCR certified water, and TE buffer 
were obtained from Teknova (Hollister, USA). 2X Assay 
Loading Reagent and 20X DNA Binding Dye Sample 
Loading Reagent were purchased from Fluidigm (San Fran-
cisco, USA). Bio-Rad (Munich, Germany) provided the 2X 
SsoFast™  EvaGreen® Supermix with Low ROX. The 2X 
 TaqMan® PreAmp Master Mix was obtained from Applied 
Biosystems (Darmstadt, Germany) and the exonuclease 
I from New England Biolabs (Frankfurt am Main, Ger-
many). Consumables for the HPLC-based quantification of 
BPDE-DNA adducts were obtained from Chromatographie 
Zubehör Trott (Kriftel, Germany). All other chemicals were 
purchased from Carl Roth (Karlsruhe, Germany).
Cell line, culture conditions and treatment 
with (+)‑anti‑BPDE
Human B-lymphoblastoid TK6 cells were purchased from 
CLS Cell Lines Service (Eppelheim, Germany). Cells were 
grown in RPMI-1640 supplemented with 10% heat-inacti-
vated FBS, 0.3 g/L l-glutamine and 2 g/L sodium bicarbo-
nate. Cells were grown at 37 °C and 5%  CO2 in a humidi-
fied incubator and were maintained between 0.08 × 106 and 
1.00 × 106 cells/mL. Shortly before the experiment, cells 
were cleaned from pre-existing mutants as described pre-
viously (Krüger et al. 2014). For storage, freshly GPI(−) 
cleansed TK6 cells were frozen with 3–5 × 106 cells per 
aliquot in 1 mL FBS with 10% DMSO (v/v).
Cytotoxicity
Cytotoxicity was determined by loss of colony forming 
ability. TK6 cells were incubated with (+)-anti-BPDE for 
1 h, washed with PBS, resuspended in RPMI-1640/FBS, 
counted, and reseeded in triplicate in 96 well plates with 
a density of 1.6 cells per well in a total volume of 100 μL 
RPMI-1640/FBS per well. After 8 days the number of 
wells with cell growth was counted and cytotoxicity was 
calculated as % of control.
Quantification of (+)‑anti‑BPDE‑induced DNA adducts
The adducts were quantified upon acidic release as tetrol 
I-1 using a HPLC/fluorescence assay described previously 
(Schwerdtle et al. 2002). Briefly, TK6 cells were incu-
bated with increasing concentrations of (+)-anti-BPDE for 
1 h. After post-incubation times of 0, 8, or 24 h aliquots 
of each 6.5 × 106 cells of the treated suspension cultures 
were collected as pellet in Tris-buffered saline (0.0027 M 
KCl, 0.0513 M NaCl, 0.025 M Tris-base, pH 7.4)/FBS 
(10%), and washed once with Tris-buffered saline (TBS). 
After DNA isolation with phenol/chloroform/isoamyl alco-
hol (25:24:1), the DNA was washed three times with 70% 
EtOH (Rotisol) and quantified (TECAN NanoQuant). The 
acidic hydrolysed DNA adducts were quantified as tetrol 
I-1 by HPLC, equipped with a Dionex UltiMate 3000 pump 
and a Gynkotek RF 2000 fluorescence detector.
Pig‑A mutation assay
Cell treatment, sample preparation, and analyses of the 
GPI(−) frequency were performed as described previously 
(Krüger et al. 2015). After treatment with BPDE for 1 h, 
TK6 cells were washed and 2 × 106 cells per treatment 
were antibody-stained in a total volume of 175 µL staining 
buffer [PBS with 1% BSA (w/v) and 0.1% sodium azide 
(w/v)]. The cells were incubated with previously pooled 
mouse anti-human CD19-APC, mouse anti-human CD55-
PE, and mouse anti-human CD59-PE for 30 min on ice 
with an additional centrifugation and resuspension step 
after 15 min. After antibody treatment, cells were washed 
twice by adding 1 mL staining buffer and gentle vortex-
ing. Subsequently, cells were incubated with 7-AAD in 
500 µL staining buffer for 10 min to exclude dead cells 
from analysis. Samples were then centrifuged, the superna-
tant was discarded and cells were fixed in 200 µL fixation 
buffer [PBS with 1% formaldehyde (v/v) and 2.5 µg/mL 
AD]. All steps prior to the flow cytometric analysis were 
performed on ice under exclusion of light. Centrifugation 
was performed at 250 × g for 5 min at 4 °C. Flow cyto-
metric analyses were conducted applying a LSR Fortessa 
from Becton–Dickinson. Excitation and emission detec-
tion of the respective fluorescence dyes were as follows: 
PE (488–575/26 nm), 7-AAD (488–695/40 nm) and APC 
(640–670/14 nm). Samples were analyzed with ~8.000 
events/s. For one determination of the GPI(−) frequency, 
 106 GPI(+) cells were collected. To exclude uninformative 
results of mutagenicity testing due to impaired cell growth 
after treatment, the relative increase in cell count (RICC) 
was assessed (Krüger et al. 2015). Directly after the respec-
tive treatment, cells were washed with PBS and seeded in 
triplicate in 24-well plates at a density of 0.1 × 106 cells/
mL in a total volume of 500 μL RPMI-1640/FBS per well. 
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After 48-h cell growth, cell numbers were determined and 
RICC was calculated as described previously:
RICC (% of control) = [(Cell number*treated −0.1 × 106)/
(Cell number*control − 0.1 × 106)] × 100, (* Cell number 
in cells/mL).
Gene expression analyses
Gene expression analyses via high-throughput RT-qPCR 
analyses with Fluidigm dynamic arrays on the BioMark™ 
System were performed as described previously (Fischer 
et al. 2016). Briefly, 10 × 106 logarithmically growing 
TK6 cells were treated with BPDE in RPMI containing 
10% FCS. After incubation, cells were washed with ice-
cold PBS and collected by centrifugation. Total RNA was 
isolated with MN  NucleoSpin® RNA Plus KIT (Mach-
erey–Nagel) according to the manufacturer’s instructions 
and quantified. 1 µg of total RNA was reverse transcribed 
in duplicate per sample into first-strand complemen-
tary DNA (cDNA) using qScript™ cDNA Synthesis Kit 
(Quanta) according to the manufacturer’s instructions. 
Before qPCR, specific target amplification (STA) and exo-
nuclease I (Escherichia coli) treatments were performed. A 
total of 5 µL STA mix was prepared containing 2.5 µL of 
2X  TaqMan® PreAmp Master Mix, 0.5 µL of the 500 nM 
pooled primer mixture, 0.75 µL of PCR certified water, and 
1.25 µL of cDNA per reaction. STA was performed in a 
thermal cycler (T100, Bio-Rad Laboratories, Munich, Ger-
many) using the following temperature program: 10 min at 
95 °C followed by 12 cycles of 15 s at 95 °C and 4 min at 
60 °C and a final holding temperature of 4 °C. Afterwards, 
0.4 µL of exonuclease I (Exo I) (initial activity 20 units/µL) 
was diluted to 4 units/µL with 0.2 µL of 10X Exonuclease I 
Reaction Buffer and 1.4 µL of PCR certified water per reac-
tion. 2 µL of the exonuclease reaction mixture were added 
to the STA samples and digestion with Exo I at 4 units/µL 
was performed according to the following temperature pro-
gram: 40 min at 37 °C, 15 min at 80 °C, and a final holding 
temperature at 4 °C. STA and Exo I-treated samples were 
diluted fivefold with 18 µL of TE buffer. For qPCR, for-
ward and reverse primers (initial concentrations 100 µM) 
were diluted to 5 µM by adding 2.5 µL of each primer 
pair to 25 µL of 2X Assay Loading Reagent and 22.5 µL 
of DNA suspension buffer. For the sample mix, 2.25 µL of 
STA and Exo I-treated samples were mixed with 2.5 µL of 
2X SsoFast™  EvaGreen® Supermix with Low ROX and 
0.25 µL of 20X DNA Binding Dye Sample Loading Rea-
gent. Preparation and loading of Fluidigm 96.96 Dynamic 
Array IFC (integrated fluidic circuit) was performed 
according to the manufacturer’s instructions. After loading, 
the chip was transferred into the BioMark™ System (Flui-
digm, San Francisco, USA) and qPCR as well as melting 
curve analysis were performed by running the following 
temperature program: 2400 s at 70 °C and 30 s at 60 °C, 
followed by a hot start for 60 s at 95 °C, 30 PCR cycles of 
5 s at 96 °C for denaturation and 20 s at 60 °C for anneal-
ing and elongation. The melting curve analysis consisted of 
3 s at 60 °C followed by heating up to 95 °C with a ramp 
rate of 1 °C/3 s. Data analysis and depiction was accom-
plished with Fluidigm Real-Time PCR Analysis and with 
GenEx software. For normalization, five potential reference 
genes were available (ACTB, B2 M, GAPDH, GUSB, and 
HPRT1). Finally, potential alterations of the transcript lev-
els of the target genes under investigation were displayed 
as fold change compared to a control group by calculat-
ing relative quantities corresponding to the ΔΔCq method 
(Livak and Schmittgen 2001).
Statistics
For statistical analyses of the data, differences between 
control and treated samples were analyzed by one-way 
analysis of variance (ANOVA) followed by the appropriate 
post hoc-test. The data were tested for homogeneity of vari-
ances via Levene test and two-sided Dunnett’s T test was 
used in case of homogeneity, whereas a two-sided Dun-
nett’s T3 test was applied upon variance inhomogeneity.
Results
Cytotoxicity
In a first step, we investigated the cytotoxicity of BPDE in 
TK6 cells after 1 h treatment. Up to 100 nM BPDE, no or 
very slight cytotoxicity was observed, determined as colony 
forming ability. At 200 nM BPDE, a significant decrease to 
50% of control occurred (Fig. 1). For subsequent experi-
ments, the low, non-cytotoxic dose range up to 50 nM was 
applied for DNA adduct quantification and mutagenicity 
testing, while the whole concentration range was applied 
for gene expression profiling to ensure the detection of 
effects occurring in the non-cytotoxic range, but also those 
effects restricted to cytotoxic concentrations.
Induction of DNA adducts by BPDE
Next, we investigated the induction of DNA adducts by 
BPDE after 1 h treatment. We applied a sensitive test sys-
tem, based on the formation of stable adducts predomi-
nantly at the N2-position of guanine and the subsequent 
release of tetrols after acid hydrolysis. The tetrols were 
very sensitively quantified by HPLC with fluorescence 
detection, allowing the quantification of as little as 1 
adduct/108 base pairs or about 60 adducts per cell, requir-
ing 10–100 µg DNA (Schwerdtle et al. 2002).
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As shown in Fig. 2, a linear dose–response was 
observed in low dose range, yielding around 100 
lesions/108 base pairs at 10 nM and around 500 
lesions/108 base pairs at 50 nM BPDE.
Induction of mutations by BPDE
Subsequently, mutations were quantified by determi-
nation of GPI-deficient cells in the newly established 
in vitro PIG-A mutation assay. Within this test system, 
inactivating mutations in the PIG-A and in the PIG-L 
gene are phenotypically expressed by the loss of GPI-
anchored proteins on the cell surface. The mutation fre-
quency is equal to the frequency of GPI-deficient cells, 
which can be determined by antibody staining of GPI-
anchored proteins and flow cytometry (Krüger et al. 
2015, 2016). As shown in Fig. 3, significantly elevated 
levels of GPI-deficient cells were observed for the entire 
concentration range, starting at 10 nM BPDE and result-
ing in about 180 GPI-deficient cells per  106 viable cells 
at 50 nM. Notably, mutations were induced in the com-
pletely non-cytotoxic concentration range of BPDE with 
respect to colony forming ability. As a parameter of cell 
growth after mutagen treatment, the relative increase in 
cell count (RICC) was determined, leading to a dose-
dependent reduction down to about 55% at 50 nM BPDE 
(data not shown). All values were well above 10% as 
recommended by the OECD to exclude uninformative 
results in mutagenicity assays. Interestingly, the increase 
in mutation frequencies was linear with dose, starting at 
the lowest concentration.
Correlation of DNA adducts and mutations
As stated in the introduction, one major question addressed 
in this study was whether or not there is a dose range in 
which DNA adducts are detectable but do not lead to the 
induction of mutations yet, perhaps due to efficient repair 
of DNA lesions in the low dose range. Therefore, muta-
tion frequencies have been plotted against DNA adducts 
quantified by HPLC. As shown in Fig. 4, there was a linear 
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Fig. 1  Cytotoxicity of BPDE determined via colony forming ability 
after 1 h treatment in TK6 cells. Shown are mean values of six deter-
minations derived from two independent experiments ± SD. Statis-
tically significant different from control: *p ≤ 0.05, ***p ≤ 0.001 
(ANOVA-Dunnett’s T test)
**
**
**y = 10.622x
R² = 0.9990
0
100
200
300
400
500
600
700
0 10 20 30 40 50
B
PD
E-
in
du
ce
d 
D
N
A
 a
dd
uc
ts
/ 
10
8 
bp
BPDE [nM]
Fig. 2  BPDE-induced DNA adduct levels determined via HPLC/
FD after 1 h treatment in TK6 cells. Shown are mean values of four 
determinations derived from two independent experiments ± SD. 
Statistically significant different from control: **p ≤ 0.01 (ANOVA-
Dunnett’s T test)
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Fig. 3  GPI(−) frequencies of TK6 cells after 1 h treatment with 
BPDE and 10 days of phenotype expression. Shown are mean val-
ues of 12 determinations derived from two independent experi-
ments ± SD. Statistically significant different from control: 
**p ≤ 0.01, ***p ≤ 0.001 (ANOVA-Dunnett’s T test)
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correlation between the amount of DNA adducts and muta-
tions in the entire concentration range of 0–50 nM BPDE.
Repair of BPDE‑induced DNA adducts
As described above, BPDE-induced DNA adducts are 
removed via NER. However, actual repair capacities could 
vary between different cells lines. To exclude that the linear 
relationship between DNA adducts and mutations is due to 
missing repair in TK6 cells and to compare repair capaci-
ties at different treatment concentrations, we quantified 
DNA adduct levels after different post-incubation times. As 
shown in Fig. 5, around 30% of the adducts were removed 
within 8 h after treatment and around 60% after 24 h. First, 
this indicates that TK6 cells are repair proficient with 
respect to NER. Second, interestingly, the relative repair 
capacity was independent of the BPDE concentration, 
suggesting that repair efficiency is not increased at lower 
lesion density in the genome.
Induction of the cellular response to BPDE‑induced 
DNA damage by gene expression profiling
To elucidate the cellular response to BPDE on the tran-
scriptional level, we applied a recently established high-
throughput RT-qPCR analyses with Fluidigm dynamic 
arrays using the BioMark™ System (Fischer et al. 2016). 
This method enables the parallel and quantitative analy-
sis of expression levels of 95 different genes for 96 dif-
ferent samples. Genes were selected according to their 
relevance for genomic stability, comprising DNA damage 
response, DNA repair factors, oxidative stress response, 
cell cycle arrest, cell proliferation and apoptosis, and 
time- and concentration-dependent analyses were per-
formed. Within the context of this study, one aspect of 
special interest concerned the question at which level of 
DNA lesions the DNA damage response would be acti-
vated on the transcriptional level. As shown in Fig. 6a, 
after 1 h incubation with BPDE and 7 h post-incubation, 
DNA damage signaling was evident most pronounced in 
case of GADD45A, followed by RRM2B. Also, the genes 
coding for the NER repair proteins DDB2 and XPC, both 
involved in DNA damage recognition, were induced. In 
each case, the effects were dose-dependent; however, rel-
evant effects reaching twofold activation were restricted 
to concentrations of 100 nM BPDE and higher. After 23 h 
post-incubation, similar effects were observed; addition-
ally, ATM involved in signaling and repair of DNA double 
strand breaks, DDIT3 as a further DNA damage induc-
ible gene as well as ERCC4 coding for a NER nuclease 
were slightly induced (Fig. 6b). Likewise, p53- and AP-1 
dependent signaling was observed in a concentration-
dependent manner, again with pronounced effects mainly 
restricted to high BPDE concentrations (Fig. 7). Regard-
ing p53-induced target genes, CDKN1A coding for the cell 
cycle inhibitor p21, the p53 inhibitor MDM2 as well as 
the p53-inducible phosphatase PPM1D displayed distinct 
inductions at 100 nM BPDE and higher; in some cases, 
slight effects occurred already at 50 nM. The effects were 
more pronounced after 23 h (Fig. 7b) as compared to 7 h 
post-incubation (Fig. 7a). The positively auto-regulated 
JUN expression indicated AP-1 activation, with a rel-
evant enhanced transcription restricted to 200 nM BPDE 
at both time points. As shown in Fig. 8, a similar dose–
response relationship was evident with respect to the 
oxidative stress response as well as apoptotic signaling, 
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exerting a clearly pro-apoptotic pattern after 1 h incuba-
tion followed by 23 h post-incubation. Thus, up to 50 nM 
BPDE no relevant modulation of gene expression was 
observed, whereas a more than twofold induction of the 
pro-apoptotic genes APAF1, BAX, and BBC3 coding for 
the p53 up-regulated modulator of apoptosis (Puma), all 
involved in the intrinsic apoptotic pathway, was evident at 
100 nM BPDE and higher. Increased mRNA levels of the 
pro-apoptotic PMAIP1 coding for Noxa and TNFRSF10B 
activating the extrinsic apoptotic pathway, as well as the 
anti-apoptotic BCL2 were even limited to 200 nM BPDE. 
Since BAX, BBC3, PMAIP1, and BCL2 are known p53 
target genes, this tumor suppressor appears to be activated 
at 100 nM BPDE and higher. Similarly, the transcrip-
tional oxidative stress response as evident by the induc-
tion of the ROS-inducible HMOX1 together with GPX1 
and SEPP1 as anti-oxidative factors occurred only at the 
highest concentration of 200 nM BPDE. The complete 
gene expression profile is provided as a heat map in Sup-
plementary Fig. 1.  
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Discussion
One critical aspect discussed within the context of risk 
assessment for chemical carcinogens consists in the 
question whether there is a general “threshold” between 
the induction of DNA adducts and their conversion into 
mutations, potentially mediated by efficient repair in 
case of only few adducts and/or protective adaptive 
mechanisms within the transcriptional response to DNA 
damage. This is of particular interest in case of low, for 
human exposure relevant levels. As stated in the intro-
duction, there have been numerous contributions stat-
ing that for alkylating agents there may be a dose range 
where DNA adducts are measurable but do not result in 
increased mutation frequencies; for recent review see 
(Klapacz et al. 2016). Nevertheless, this raises the ques-
tion whether this is a general phenomenon or restricted to 
certain DNA lesions.
Within the present study, we selected BPDE, the criti-
cal DNA reactive metabolite of BaP, which provokes helix 
distorting lesions in DNA repaired by NER, to address 
the question whether there is a concentration range where 
DNA adducts occur without measurable increase in muta-
tion frequencies. We quantified stable DNA adducts at the 
N2-position of guanine, mutations by the PIG-A assay, as 
well as the transcriptional response to DNA damage via a 
high-throughput qRT-PCR technique. Important prerequi-
sites to approach this question were comparable incuba-
tion conditions, including the identical cell line, in this case 
TK6 cells, expressing the GPI anchored proteins used as 
marker proteins for mutagenicity. Also, with regard to the 
different endpoints, similar detection sensitivities for the 
low dose range were of major importance, to exclude that 
a potential restriction of mutations to higher concentrations 
results from higher detection limits as compared to DNA 
adduct levels.
Regarding the quantification of DNA lesions, BPDE-
DNA adduct levels were measured by a highly sensitive 
HPLC/fluorescence assay described previously (Schwerdtle 
et al. 2002). The principle of the procedure consists in the 
hydrolysis of stable DNA adducts formed at the N2 posi-
tion of guanine by 0.1 N HCl, yielding the corresponding 
tetrol I-1 (Rojas et al. 1994). Under our experimental con-
ditions, the assay exerts a detection limit of 1 pg of tetrol 
I-1, requires 10–100 µg DNA and detects 1 adduct/108 
base pairs or about 60 adducts/cell. This high sensitivity 
allows the reproducible quantification of adduct formation 
and repair after incubation with low, non-cytotoxic con-
centrations of BPDE. Within the present study, significant 
increases in lesions were detected at concentrations as low 
as 10 nM, with a linear increase up to 50 nM BPDE. For 
comparison, immunological detection required 25-fold 
higher concentrations (0.25 µM and above) (Christmann 
et al. 2016). Regarding the repair of the adducts, only 30% 
were removed within 8 h post-incubation time, and 40% 
were still left after 24 h. This repair course is in agreement 
with previous observations in A549 and HCT116 cells 
(Grosskopf et al. 2010; Piberger et al. 2014; Schwerdtle 
et al. 2002), supporting similar repair capacities in different 
cell lines. Interestingly, repair kinetics were independent of 
the applied dose, indicating that within this low dose range 
of BPDE, no differences in relative repair were observed, 
and thus, no dose showed faster or even complete repair. 
This may be explained by specific features of NER mediat-
ing the repair of stable BPDE-DNA adducts. NER removes 
structurally unrelated bulky base adducts generating sig-
nificant helical distortions. According to the current knowl-
edge, it involves at least 30 different proteins and enzymes 
Fig. 8  Impact of BPDE on 
gene expression related to 
oxidative stress response and 
apoptotic signaling. TK6 cells 
were treated with BPDE for 
1 h followed by 23 h post-
incubation. Shown are linear 
fold changes of the relative gene 
expression from mean values 
of four determinations derived 
from two independent experi-
ments ± SD
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in mammalian cells, including those which are defective in 
patients suffering from the DNA repair disorder Xeroderma 
Pigmentosum (XP) complementation groups A through G 
(de Boer and Hoeijmakers 2000). Two different pathways 
can be distinguished: the global genome repair (GG-NER) 
operating in all parts of the genome and the transcription-
coupled repair (TC-NER) eliminating DNA damage from 
the transcribed strand of active genes. While TC-NER is 
usually fast and efficient to restore transcription, GG-NER 
on the other hand is slower and may be incomplete, lead-
ing to an accumulation of mutations in poorly repaired 
regions (Fousteri and Mullenders 2008; Mullenders et al. 
1991). Accordingly, three levels of repair efficiencies have 
been identified in human fibroblasts after treatment with 
BPDE: The transcribed strand of the active HPRT gene 
was repaired about twice as fast as the non-transcribed 
strand, resulting in 53 and 26% of adduct removal after 7 h, 
respectively. In contrast, only 14% of BPDE adducts were 
removed from the inactive locus 754 within 20 h (Chen 
et al. 1992). In addition, the rates of incision of stereo-
chemically identical BPDE-induced DNA lesions catalyzed 
by the prokaryotic UvrABC system was shown to be higher 
in the TG*T than in the CG*C sequence context (Ruan 
et al. 2007), due to differences in structural alterations of 
the DNA helix (Cai et al. 2007). The longevity of at least 
some PAH-induced DNA adducts was also shown in lung 
autopsy samples of non-smokers, ex-smokers, and smok-
ers. Lowest frequencies of lesions were found in the first 
group, intermediate frequencies in the second, and highest 
values in the third group. Furthermore, almost all samples 
even of the non-smoking group had detectable levels of 
PAH-induced DNA lesions, indicating that even low levels 
of environmental exposure lead to unrepaired DNA adducts 
(Lodovici et al. 1998).
In this study, mutations induced by BPDE were quan-
tified by the recently established PIG-A assay. This 
approach is based on the phenotypic alteration of the GPI 
status by mutations diminishing the GPI biosynthesis, 
which can be measured via multicolor flow cytometry 
with an antibody staining protocol of GPI-anchored pro-
teins CD55 and CD59. In addition to the X-chromosomal 
PIG-A gene, TK6 cells have been shown to additionally 
harbour a heterozygous deletion in the PIG-L gene. Since 
both gene products are required for GPI biosynthesis, 
there are two reporter genes leading to the same pheno-
typic alteration, rendering this test system particularly 
sensitive towards both point mutations and deletions, also 
when compared to the HPRT assay (Krüger et al. 2015, 
2016). Previously, we demonstrated the dose-dependent, 
statistically significant mutagenicity of ethyl methane-
sulfonate (EMS), UV-C irradiation, and 4-nitrochino-
line-N-oxid (NQO), while pyridine and cycloheximide, 
applied as non-mutagenic negative controls, were also 
correctly identified as non-mutagens (Krüger et al. 2015). 
Within the present study, BPDE increased the level of 
GPI-deficient mutant cells in a dose-dependent manner, 
with no obvious deviation from linearity also at the low-
est concentrations. Furthermore, there was a linear corre-
lation between DNA adduct formation and mutagenicity, 
again arguing against a “no effect” range in the low dose 
exposure towards BPDE.
The transcriptional response to BaP or BPDE-induced 
DNA damage has been investigated previously, for exam-
ple via microarray analysis to elucidate the impact of p53 
(Hockley et al. 2008). Also, recently, the adaptive up-regu-
lation of selected DNA repair genes was analyzed and cor-
related to BPDE-induced DNA adduct levels, showing that 
transcriptional activation protects against BPDE-induced 
cytotoxicity at the expense of mutations; the latter due to 
the enhanced expression of error-tolerating POLH (Christ-
mann et al. 2016). Nevertheless, to the best of our knowl-
edge, no gene expression analysis study was conducted in 
the very low concentration range of 10–200 nM BPDE as 
it is presented within this study. Furthermore, we applied 
a high-throughput RT-qPCR technique, enabling quantita-
tive time- and concentration-dependent gene expression 
analyses for 96 samples in parallel, providing a comprehen-
sive gene expression profile with respect to DNA damage 
response, DNA repair factors, oxidative stress response, 
cell cycle arrest, cell proliferation, and apoptosis. Special 
focus was given to time- and concentration-dependent 
inductions of gene expression coding for representative 
factors of the above-mentioned pathways with special rel-
evance for genomic stability, investigated under the same 
incubation conditions as used for DNA adduct and muta-
tion quantifications. As expected, treatment with BPDE 
induced genes coding for DNA damage signaling such as 
GADD45A, DNA repair factors involved in DNA damage 
recognition during NER, p53 and AP-1 dependent signal-
ing, as well as those coding for oxidative stress response 
and pro-apoptotic factors. However, almost all significant 
changes in gene expression were restricted to the two high-
est concentrations applied, 100 and 200 nM BPDE, while 
highly significant increases in mutation frequencies were 
observed at concentration levels 10- and 20-fold lower. 
Therefore, neither the induction of DNA repair genes nor, 
for example, p53-dependent cell cycle control or apoptotic 
genes were able to protect against BPDE-induced muta-
tions in the very low dose range.
This raises the question how BPDE-induced DNA 
adducts are converted into mutations. BPDE-induced DNA 
adducts impair DNA synthesis as well as global replica-
tion fork progression, and two mechanisms appear to be 
associated with overcoming stalled replication fork upon 
BPDE-induced DNA adducts. One consists in lesion 
bypass by mainly error-prone DNA translesion synthesis 
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(TLS) polymerases. This process is thought to be critical 
for BaP-caused mutagenicity via the induction of point 
mutations and has been extensively studied (Bi et al. 
2005; Lagerqvist et al. 2011; Temviriyanukul et al. 2012). 
Additionally, stalled or damaged replication forks may be 
restarted or repaired via homology-dependent mechanisms 
(Cohen et al. 2015; Dumstorf et al. 2009; Izhar et al. 2013; 
Langie et al. 2007). Even though homologous recombina-
tion (HR) and HR-dependent mechanisms are intrinsically 
error-free, recombination could give rise to gross chromo-
somal instabilities such as genomic rearrangements or loss 
of heterozygosity when promoted by micro-homology or 
any other homologous sequence near the fork (Carr and 
Lambert 2013). Further investigations are needed to clar-
ify whether mutations induced in response to low dose of 
BPDE as applied in the present study are exclusively medi-
ated via error-prone TLS or might be in part induced by HR 
events as well.
Conclusions and outlook
Our study seems to contradict assumptions of a general 
“biological threshold” for genotoxic carcinogens. Thus, 
in case of BPDE-induced DNA adducts, both DNA lesion 
induction, as well as mutagenicity followed linear dose–
response relationships in the very low dose range, and were 
highly correlated. In contrast, the transcriptional response 
to DNA damage was restricted to higher, partly cytotoxic 
concentrations. One reason for the discrepancy between 
the linear correlation of DNA damage and mutations 
shown here and the reported “threshold” in response to 
some alkylating agents appears to be the impact of differ-
ent types of DNA lesions, especially also different types of 
DNA repair systems involved in their removal. Without any 
doubt, NER is a largely error-free process, which protects 
from mutagenicity, including BPDE-induced DNA adducts 
(Lagerqvist et al. 2011). Nevertheless, NER may be less 
effective as compared to BER involved in the removal of 
different DNA lesions induced by alkylating agents. While 
the latter repair system removes DNA lesions that also 
occur endogenously, nucleotide excision repair is involved 
in the removal of bulky lesions, frequently induced by envi-
ronmental carcinogens. As described above and shown 
within the present study, NER has been shown to be slower 
and less effective, due to heterogeneity of repair throughout 
the genome and also with respect to the DNA sequence in 
which the lesion is located. Nevertheless, even though DNA 
repair capacities were found to be similar in different cells 
lines, they may differ in vivo in different tissues; this needs 
to be further investigated. This aspect also accounts for the 
transcriptional response to DNA damage. Altogether, our 
results indicate that the question of a “threshold” between 
the induction of DNA lesions and their conversion into 
mutations needs to be considered on a case-by-case basis, 
taking into account different DNA repair systems and 
respective lesions. Whether or not our observations derived 
for treatment with BPDE also apply to other substrates of 
NER requires future research.
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